Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
FDA Approves First-of-its-Kind Treatment for Polycythemia Vera
In 2019, Blood Cancer United, in partnership with the MPN Research Foundation, funded a grant which expanded the scientific understanding related to h…
News
From sketchbook to speedway: One child's dream drives hope for kids with blood cancer
Twelve-year-old cancer survivor's custom design for William Byron's No. 24 Valvoline™ Chevrolet aims to inspire joy, raise awareness and drive support…
News
Blood Cancer Treatment Advances Have Saved Nearly 26 Million Years of Life Over Past 75 Years
New analysis introduces a life-years saved methodology to track how research funding, health care policy and access to treatment translate into more t…
News
The 2026 Light The Night Season Launches During Blood Cancer Awareness Month
Blood Cancer United is launching its signature community event, Light The Night, during Blood Cancer Awareness Month. Beginning this September and con…
News
FDA Approves First-of-its-Kind Treatment for Multiple Myeloma
“We continue to be encouraged by the sustained progress being made in myeloma research and remain hopeful that advances like this will lead to better …
News
The Leukemia Ball Becomes the Blood Cancer United Ball
In alignment with the recent organization-wide rebrand of The Leukemia & Lymphoma Society (LLS) to Blood Cancer United, the black-tie event will now b…
News
Blood Cancer United Endorses YES on Prop 38 to Support Medical Research for Cancer and Other Serious Illnesses
Blood Cancer United has endorsed YES on California Proposition 38, a ballot measure that would fund breakthrough immunology research aimed at preventi…
News
New Secret Shopper Report Finds Consumers Seeking Affordable Health Coverage Are Being Steered Toward Inadequate Plans
Georgetown University study—funded by Blood Cancer United—reveals misleading marketing of limited-benefit plans that expose consumers to high medical …
News
Beat AML® Study Provides New Data on 14-Day vs. 28-Day Venetoclax-Azacitidine Treatment in AML
Clinicians often reduce the duration of venetoclax because of side effects, but study finds 14-day schedule fell short in older patients with newly di…
News
The Harry T. Mangurian, Jr. Foundation Surpasses $25M in Support With New $4M Commitment
The Harry T. Mangurian, Jr. Foundation has made a new $4 million commitment to Blood Cancer United, bringing the foundation's total support to more th…
News
FDA Approves Injectable Version of Myeloma Treatment
“This marks continued progress in making effective therapies more accessible and manageable for people living with blood cancer,” said Lore Gruenbaum,…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
